Dr. Stephen Friend is president of Sage Bionetworks, a nonprofit biomedical research organization that aims to create a revolutionary open access approach to human biological information and the treatment of disease. Previously senior vice president and franchise head for oncology research at Merck & Co., Friend led Merck's basic cancer research efforts. Prior to that he joined the Fred Hutchinson Cancer Research Center′s Seattle Project, an advanced institute for drug discovery. He has also held faculty positions at Harvard Medical School and Massachusetts General Hospital. He received a B.A.in philosophy, a Ph.D. biochemistry, and an M.D. from Indiana University.

Panel:
Panel - Business Is from Mars, Academia Is from Venus